Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Phase 2 data in type 2 diabetes showed CagriSema reduced HbA1c by 2.2 percentage points compared to 1.8 with semaglutide alone and 0.9 with cagrilintide alone, while achieving 15.6% weight loss versus 5.1% with semaglutide alone
Non-intensive investigation with low-exposure level 5-aza-2'-deoxycytidine (DAC) prior [PMID: 19363531] Laboratory literature summary: Non-intensive investigation with low-exposure level 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML research
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Hormone therapy can restore vitality, making it easier to stay on task and follow through on goals
BPC 157 promotes healing processes, offering a comprehensive approach to managing and treating inflammatory bowel diseases
Study that gives important insight into the molecular mode of action of GLP-1 by identifying the cellular localization of GLP-1R in monkey and human tissue using the most extensively validated monoclonal antibody to date
